The labs associated with The Brain Tumor Center represent the four signature research programs: Convergence Science, Immunotherapy, Tumor Biology, and Epigenetics.
Convergence Science

Kim Lab
Laser-based surgery; LITT and the tumor microenvironment; Cancer stem cells and metabolism; Cancer stem cells and therapeutic resistance
Albert H. Kim, MD, PhD

Mathios Lab
Developing genomic and epigenomic liquid biopsy approaches for non-invasive detection of brain tumors.
Dimitrios Mathios, MD

Stegh Lab
Nanoscale therapeutics; Nanoscale therapeutics innate immunity; Cancer metabolism, Metabolism and Epigenetic control
Alexander H. Stegh, PhD
Immunotherapy

Kim Lab
Laser-based surgery; LITT and the tumor microenvironment; Cancer stem cells and metabolism; Cancer stem cells and therapeutic resistance
Albert H. Kim, MD, PhD

Stegh Lab
Nanoscale therapeutics; Nanoscale therapeutics innate immunity; Cancer metabolism, Metabolism and Epigenetic control
Alexander H. Stegh, PhD
Tumor Biology

Kim Lab
Laser-based surgery; LITT and the tumor microenvironment; Cancer stem cells and metabolism; Cancer stem cells and therapeutic resistance
Albert H. Kim, MD, PhD

Mathios Lab
Developing genomic and epigenomic liquid biopsy approaches for non-invasive detection of brain tumors.
Dimitrios Mathios, MD

Stegh Lab
Nanoscale therapeutics; Nanoscale therapeutics innate immunity; Cancer metabolism, Metabolism and Epigenetic control
Alexander H. Stegh, PhD
Epigenetics

Kim Lab
Laser-based surgery; LITT and the tumor microenvironment; Cancer stem cells and metabolism; Cancer stem cells and therapeutic resistance
Albert H. Kim, MD, PhD

Stegh Lab
Nanoscale therapeutics; Nanoscale therapeutics innate immunity; Cancer metabolism, Metabolism and Epigenetic control
Alexander H. Stegh, PhD